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Abstract
Electronic (e)-cigarette use is rapidly rising, with 20 % of
Americans ages 25–44 now using these drug delivery devices.
E-cigarette users expose their airways, cells of host defense,
and colonizing bacteria to e-cigarette vapor (EV). Here, we
report that exposure of human epithelial cells at the air–liquid
interface to fresh EV (vaped from an e-cigarette device) result-
ed in dose-dependent cell death. After exposure to EV, cells of
host defense—epithelial cells, alveolar macrophages, and neu-
trophils—had reduced antimicrobial activity against
Staphylococcus aureus (SA). Mouse inhalation of EV for 1 h
daily for 4 weeks led to alterations in inflammatory markers
within the airways and elevation of an acute phase reactant in
serum. Upon exposure to e-cigarette vapor extract (EVE), air-
way colonizer SA had increased biofilm formation, adherence
and invasion of epithelial cells, resistance to human antimicro-
bial peptide LL-37, and up-regulation of virulence genes. EVE-
exposed SAwere more virulent in a mouse model of pneumo-
nia. These data suggest that e-cigarettes may be toxic to airway
cells, suppress host defenses, and promote inflammation over
time, while also promoting virulence of colonizing bacteria.
Key message
& Acute exposure to e-cigarette vapor (EV) is cytotoxic to
airway cells in vitro.
& Acute exposure to EV decreases macrophage and neutro-
phil antimicrobial function.
& Inhalation of EV alters immunomodulating cytokines in
the airways of mice.
& Inhalation of EV leads to increased markers of inflamma-
tion in BAL and serum.
& Staphylococcus aureus become more virulent when ex-
posed to EV.
Keywords E-cigarette vapor . Staphylococcal virulence .
Cytotoxicity . Inflammatory lung disease . Antimicrobial
peptide LL-37 .MRSA pneumonia
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Introduction
Electronic (e)-cigarette Bvaping^ is the inhalation of an elec-
trically heated and aerosolized liquid containing nicotine. E-
cigarettes were invented in 2003 and rapidly gained popularity
through adolescent and adult smokers of all ages, sexes, and
races [1]. E-cigarette use is tripling annually, with use increas-
ing in both non-smoking and smoking children and adults
[2–5]. Cigarette smokers who also use e-cigarettes do not have
higher rates of intention of quit [6–8]. Annual sales of e-
cigarettes now total $2 billion, and analysts predict they will
outsell traditional cigarettes within 10 years. E-cigarette
makers are flavoring and naming their wares to appeal to
children and women, who prefer sweet flavors [9]. One in
ten high schoolers have tried e-cigarettes in the past year,
double that of the year prior [1]. Therefore, e-cigarette use is
creating a new generation of nicotine addicts. Despite being
advertised as a safe alternative to conventional combustible
cigarettes, little is known about e-cigarettes’ safety and their
potentially deleterious effects on health.
E-cigarettes are composed of a cartridge of Be-liquid,^
which contains propylene glycol (PG) and/or vegetable glyc-
erin (VG) plus nicotine. Many users mix their own e-liquid so
that they can modify the nicotine content [10]. Nicotine ab-
sorption into the bloodstream is similar in the latest generation
of e-cigarettes compared to conventional cigarettes [11]. E-
liquid is introduced into a cartridge, which also contains an
atomizer and heating vapor coil to produce the vapor. This
cartridge is attached to a rechargeable battery.
The pathogenic bacteria Staphylococcus aureus (SA) per-
sistently colonizes 20 % of humans and transiently colonizes
60 % [12]. We recently demonstrated that conventional ciga-
rette smoke promotes SA pathogenicity via a general stress
response and leads to increased virulence in vivo [13].
Suggesting that susceptibility of smokers to bacterial
infections may be due in part to pro-virulent effects on
colonizing bacteria. Because colonizing SA strains in the na-
sopharynx are exposed to all inhaled substance, including e-
cigarette vapor (EV), we hypothesize that EV may affect SA
pathogenicity.
The many toxic, inflammatory, and carcinogenic effects of
conventional cigarette smoke have been well characterized
over the past century [14]. However, it is unknown whether
vaping e-cigarettes will also increase the incidence of inflam-
matory, infectious, or malignant lung diseases or systemic
diseases. To evaluate the potential impact of e-cigarette use
on susceptibility to bacterial infections and development of
inflammatory responses, we undertook these studies of e-
cigarette effects on both host and pathogen functions.
Methods
E-cigarettes
E-cigarettes were purchased from San Diego County gas sta-
tions and vaporiums, as well online from Xtreme Vaping.
Flavored and unflavored e-liquids were selected, as well as
with and without nicotine (Table 1). E-liquid was never added
directly to media or cells; all exposures were done by creating
aerosol (Bvapor^) with e-cigarette devices, via application of
voltage to the heating coil within the e-liquid, and aerosoliza-
tion. Unless otherwise noted, the e-cigarette liquid was mixed
in the lab, using 50%PG, 50%VG, and 24mg/mL (148mM)
nicotine (PG + VG +N; a common blend of e-liquid, based on
content labels on multiple brands of e-cigarettes and by blogs
of e-cigarette users who make their own e-liquid). Cartridges
and batteries were bought from Xtreme Vaping, with each e-
liquid brand having a dedicated cartridge, except the brands
Table 1 E-cigarette brands and composition
Brand Materials Type Flavor
Free Masons Elixer PG/VG with 14 mg/mL Nic E-liquid Treasury
Green Smart Living PG/VG with 0.6 % (low) Nic Vape pen with cartridges containing e-liquid None
PG/VG with 1.8 % (high) Nic
Grimm Creations PG/VG with 18 mg/mL Nic E-liquid Highlander Grog
NJoy PG Vape pen containing e-liquid None
Vape Addict Juices PG/VG with 18 mg/mL Nic E-liquid California Blues
Vapure PG/VG with Nic E-liquid None
Xtreme Vaping e-liquids: PG, VG Refillable vape pens for all brands of e-liquids
and mixable liquids
None
Nic: 50 mg/mL in PG
Lithium batteries
Cartridges/Tanks
Xtreme Vaping 80 % PG/20 % VG with 24 mg/mL Nic E-liquid Pure smoke
PG propylene glycol, VG vegetable glycerin, Nic nicotine
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that came pre-loaded (NJoy and Green Smart Living (GSL))
(Table 1).
E-cigarette vapor extract
See Supplementary material.
Cells and culture methods
Two types of human epithelial cells were used for these stud-
ies—human keratinocytes (HaCaTs; CLS) and human lung
alveolar type II epithelial cells (A549 cells; ATCC CCL-
185) [15]. Both cell types express nicotinic receptors, which
are believed to play a role in lung cancer pathogenesis [16,
17]. HaCaTs express nicotinic acid receptors GPR109A and B
[18], while A549 cells express α5-nicotinic acetylcholine re-
ceptors (nAChRs) [19, 20]. HaCaTs and A549s were cultured
in RPMI + 10 % fetal bovine serum (FBS). MH-S cells
(ATCC CRL-2019) were cultured in RPMI + 10 % FBS +
0.05 mM beta-mercaptoethanol. MRSA USA300 was used
for all mammalian cell infections and bacterial studies.
Cultures of MRSA were started the day prior to assays and
grown overnight in Todd Hewitt Broth (THB) at 37 °C with
shaking. Control media and e-cigarette vapor extract (EVE)
for mammalian cell studies were made using RPMI 1640 +
10 % FBS as the base media. EVE and control media for
bacterial cell exposure were made with the addition of a small
fraction of bacteriologic media: RPMI 1640 + 10 % FBS +
20 % THB as the base media. Both of these medias are ac-
cepted methods for CSE studies [21, 22]. Same-day MRSA
subcultures were prepared in control media and 75 % EVE
and grown to mid-log phase (OD600 0.6–0.8) before centrifu-
gation (1620×g, 10 min) and resuspension at 1×108 colony-
forming units (CFU)/mL (OD600 0.4) prior to dilution in assay
media to the final CFU/mL. For macrophage assays, MRSA
were pre-opsonized with mouse serum (Applied Biosystems)
and incubated with 1×105 MH-S macrophages at a multiplic-
ity of infection (MOI) of 0.1. For human neutrophil assays,
MRSAwere pre-opsonized with human serum for 30 min and
then incubated for 2 h with neutrophils at an MOI of 0.1. For
enumeration, MRSAwas serially diluted and plated on THA.
Exposure of epithelial cells and macrophages to EVE
and EV
See Supplementary material.
Neutrophil isolation from fresh human blood
See Supplementary material.
Bacterial killing by keratinocytes, macrophages,
and neutrophils
See Supplementary material.
Mouse inhalation of e-cigarette vapor
Female CD-1 mice, 6–8 weeks old from Jackson Labs, were
used for all studies. The SciReq inExpose system was used to
limit EVeffects to the respiratory tract. Mice were exposed to
9 s of EV per minute for 60 min. Experimental controls were
also placed in mesh holders but breathed air alone (Air).
Negative controls were kept in the mouse facility (Control).
Mice were recovered in pre-warmed cages for 1 h. Mice were
euthanized 24 h after their final exposure via inhaled CO2.
Blood was collected by intracardiac puncture followed by
bronchoalveolar lavage (BAL) with 1 mL phosphate-
buffered saline (PBS) three times. Right lung lobes were
placed in RNA later. The left lobe was inflated with 4 %
paraformaldehyde (PFA) for paraffin embedding and H&E
and trichrome staining for blinded histologic analysis. BAL
cells were counted via trypan blue exclusion, cytospun, and
stained with GiemsaWright for cell differential analysis. BAL
cells and parenchymal lung cells were stained for multiple
leukocyte markers and evaluated by flow cytometry. Blood
was spun at 1620×g for 10 min to isolate serum. Serum and
BAL supernatant were stored at −80 °C until use. All animal
experiments were approved by both the VA and UCSD
IACUC.
Proteome evaluation
Proteome profiler array (mouse cytokine array panel A, R&D
Biosystems) was used according to manufacturer’s instruc-
tions. Briefly, 1-mL samples were incubated with nitrocellu-
lose membranes at 4 °C overnight. Membranes were washed,
streptavidin-horseradish peroxidase applied, followed by
chemiluminescent reagents. Membranes were exposed to film
and processed through a developer.
Bacterial growth curves, biofilm formation,
and hydrophobicity assays
See Supplementary material.
Adherence and invasion of human keratinocytes
See Supplementary material.
Antimicrobial peptide (LL-37) resistance and surface
charge assays
See Supplementary material.
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Murine MRSA pneumonia
Female CD-1 mice (6–10 weeks old, Charles River) were
sedated with ketamine/xylazine and infected intranasally with
2×108 CFU MRSA in 75 μL. Mice were kept upright for
1 min and recovered with heads elevated at 30°. Mice were
checked twice daily, with mortality and weight documented
every 24 h. On day 4 post-infection, live mice were harvested
via CO2 asphyxiation. Left lungs were inflated with 10 % for-
malin for histology. Right lungs were weighed and homoge-
nized using 1.0-mm zirconia/silica beads (Bio Spec Products)
andMagNA Lyser (F. Hoffmann-La Roche). Of undiluted lung
homogenate, 100 μL was spread on a THA plate, and the
remainder was serially diluted and plated to enumerate surviv-
ing bacteria. Pneumonia experiments were repeated three times.
All methods were approved by the VA IACUC, protocol no.
11-017. All efforts were made to minimize animal suffering.
qRT-PCR of MRSA
See Supplementary material.
Statistics
See Supplementary material.
Results
E-cigarette vapor extract reduces keratinocyte
antimicrobial activity
Epithelial cells are the front-line defense against invasion and
infection. To examine how EVaffects host defense in the respi-
ratory tract, we used e-liquid containing 50 % PG, 50 % VG,
and nicotine, both 8 and 24 mg/mL (49 and 148 mM), which
are common high and low nicotine concentrations used
by humans. E-liquid was placed into the cartridge of an
e-cigarette device and generated the aerosol (vapor). The vapor
was bubbled through media to make EVE, and the EVE was
applied to human keratinocytes (HaCaTs). HaCaTs are a
well-established model for nasopharyngeal epithelium, one of
the main sites of SA colonization and the gateway to the lungs,
and give consistent results due to clonality [23, 24]. HaCaTs
express nicotinic acid receptors GPR109A and B [18]. HaCaTs
were exposed to EVE for 1 h at 37 °C with 5 % CO2, followed
by 2 h recovery in regular (e-cigarette vapor-free) media.
Bacteria were not exposed to EVE.
Exposure of HaCaTs to EVE made from 24 mg/mL
(148 mM) nicotine e-liquid (EVE High Nic) prior to bacterial
infection led to 25 % greater methicillin-resistant S. aureus
(MRSA) numbers compared to control (P<0.001; Fig. 1a).
Nicotine had a dose effect, with EVE made from 8 mg/mL
(49 mM) nicotine e-liquid (EVE Low Nic) resulting in fewer
bacteria compared to EVE High Nic but more bacteria com-
pared to control (P<0.01; Fig. 1a).
Exposure to e-cigarette vapor at the air–liquid interface
induces cell death in epithelial cells
To determine whether the decreased ability to control the
Staphylococcal infection was due to cell death induced by
EVE, HaCaTs were exposed to EVE, allowed to recover for
2 h, harvested, and enumerated by trypan blue exclusion. For
increased physiologic relevance, human epithelial cells
(HaCaTs and A549s) were grown on transwells with the api-
cal surface exposed to air or EV. Both direct exposure of the
apical cell surface to EVand incubation in EVE led to signif-
icant cell death, ranging from 50 to 70 % for vapor made from
PG and PG + N and 99 % for vapor made from VG and VG +
N (air-interface data shown in Fig. 1b). Nicotine at 2 mg/mL
in media applied to the apical surface of cells for 15 min killed
32 % of cells. Addition of nicotine to the e-liquid base PG
increased cytotoxicity by 20 %. No difference was seen when
nicotine was added to VG (VG + N); however, this may have
been due to maximal cytotoxicity seen byVG alone. Exposure
of A549 cells to EVE induced cell death in a dose-dependent
manner (Fig. 1c).
Multiple e-cigarette brands were tested to determine wheth-
er the cytotoxic effect was generalizable. Cytotoxicity was
seen with four of the six additional brands. Direct exposure
on air–liquid interfaces led to 96, 99, 97, and 41 % cell death
with Pure Smoke, Vapure, Treasury, and Highlander Grog,
respectively (Fig. 1d). Cell death was no different at 2 and
18 h post-exposure. Addition of flavors to e-liquids did not
influence cytotoxicity. Exposure to NJoy, a pre-loaded car-
tridge type e-cigarette, and Cali Blues, an e-liquid added to a
conventional e-cigarette for vaping (Table 1), did not induce
cytotoxicity.
Cell death caused by e-cigarette vapor exposure occurs
through necrosis
To characterize the method of cytotoxicity induced by e-
cigarette vapor exposure, lactate dehydrogenase (LDH)
levels were measured in A549 cells after exposure to vaped
e-liquid components. Compared to LDH release from air-
exposed A549 control cells, exposure to each vaped e-
liquid component led to significantly higher levels of
LDH released into the supernatant (Fig. 1e). The high
levels of LDH found within 2 h of EV exposure are indic-
ative of necrotic cell death. Cells also stained positively for
EthD-IIIi and surface Annexin-V 2 h after exposure
(Supplemental Fig. S1).
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E-cigarette vapor extract reduces macrophage
antimicrobial activity
Alveolar macrophages (AMs) are pivotal regulators of
inflammatory signals that orchestrate innate immune re-
sponses against infectious pathogens, and they are respon-
sible for clearance of inhaled/aspirated bacteria. Exposure
of MH-S cells to EVE led to a reduction in antimicrobial
activity. Pre-exposure of AMs to EVE High Nic led to
535 % higher MRSA numbers compared to MRSA recov-
ered from control macrophages (P < 0.0001; Fig. 2a).
Exposure of MH-S cells to EVE Low Nic resulted in
395 % greater MRSA numbers (P < 0.001). The over-
growth of MRSA in the presence of macrophages exposed
to EVE High Nic, where MRSA were able to completely
resist killing and grow, may be due to impairment of mac-
rophage antibacterial functions by EVE.
E-cigarette vapor extract from multiple brands reduces
neutrophil antimicrobial activity in a nicotine
concentration-dependent manner
Human polymorphonuclear leukocytes (hPMNs) play a vi-
tal role in host defense of the lungs against bacterial
pathogens and are found in abundance in the airways of
conventional cigarette smokers—the largest population of
current e-cigarette users. hPMNs isolated from blood were
used for these studies. Once primed and exposed to acti-
vating stimuli, such as bacteria, blood hPMNs have func-
tion similar to mature neutrophils within sites of inflamma-
tion and infection [25]. EVE exposure of hPMNs reduced
antimicrobial function, leading to 46 % greater MRSA
numbers after EVE High Nic exposure (P < 0.05;
Fig. 2b). Bacteria were not exposed to EVE.
Each of the innate immune cell types tested, epithelial
cells, AMs, and hPMNs, had decreased abilities to kill and
control MRSA growth at higher nicotine concentrations,
suggesting that nicotine suppresses antimicrobial function
in multiple cell types in a dose-dependent manner. To eval-
uate the effect of nicotine, separate from that of EV, we ran
infection assays with nicotine added directly to media.
Because neutrophils are one of the most relevant airway
cells to the main e-cigarette using population, we utilized
them for the remaining in vitro studies. hPMNs were incu-
bated with incremental concentrations of nicotine (0.4, 1.0,
and 2.0 mg/mL–2.5, 6, and 12 mM; similar to serum nic-
otine levels in cigarette smokers and e-cigarette users—
therefore less than levels in airways exposed to inhalants).
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Fig. 1 E-cigarette vapor exposure decreases the ability of keratinocytes
to fight bacterial infection via induction of cell death. a Keratinocytes
exposed to EVE containing low nicotine (8 mg/mL, 49 mM, prior to
vaping; EVE Low Nic) and high nicotine (24 mg/mL, 148 mM, prior to
vaping; EVE High Nic) or control (no EVE) for 1 h, followed by 2 h
recovery in regular media, were unable to control MRSA growth during
infection. b Exposure of the apical cell surface to the three most common
e-cigarette vapor components (each was aerosolized via e-cigarette
devices) or control (air only, no EV) for 15 min, followed by 2 h
recovery, led to significant keratinocyte cell death, as measured by
trypan blue exclusion. c Exposure of the human airway epithelial cell
line A549 to EVE also led to cytotoxicity, in a dose-dependent manner.
d Multiple different brands of e-cigarette vapors caused cell death. e
Cytotoxicity was confirmed via LDH release assays. All conditions
were run in triplicate and experiments were run ≥3 times. *P < 0.05,
**P< 0.01, ***P< 0.001, ****P< 0.0001
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Moderate suppression of hPMN antimicrobial function
was found, with increased MRSA survival by 17 %
(2.5 mM), 25 % (6 mM), and 27 % (12 mM) were found,
respectively (Fig. 2c).
The modest effect of nicotine on antimicrobial function
suggests that other elements of EV may be playing a role.
We vaped PG and VG on their own and vaped PG and VG
with nicotine (+N). Each vaped component led to increased
bacterial survival when hPMNs were infected post-exposure
(Fig. 2d). The addition of nicotine into the e-liquid bases (PG
+ N and VG + N) further reduced killing capacity of neutro-
phils, and increased the corresponding numbers of MRSA
(Fig. 2d), demonstrating that nicotine also causes hPMN
dysfunction.
Lastly, we tested EVE from six popular brands.
Neutrophil exposure to four of the brands increased
MRSA survival and growth relative to control (Fig. 2e).
E-liquid without flavor (Vapure in Fig. 2e and Xtreme
Vaping in Fig. 2d) resulted in similar bacterial survival as
those with flavors (Pure Smoke, Treasury, and Highlander
Grog). No difference in bacterial counts was observed
when neutrophils were exposed to EVE made from NJoy,
a pre-loaded cartridge type e-cigarette system, or
California Blues flavored e-liquid.
Mouse inhalation of e-cigarette vapor leads to increased
levels of inflammatory cytokines in bronchoalveolar
lavage
Mice inhaled EV for 60min, once daily, for 4 weeks. Total cell
counts in the BAL fluid were no different in e-cigarette mice
compared to experimental air-exposed controls (n=6mice per
group; Fig. 3a). There were no alterations in the types of cells
patrolling the airways, with >99 % macrophages and <1 %
neutrophils, eosinophils, and lymphocytes in BAL of all
groups (Fig. 3b, c). By flow cytometry, there was no differ-
ence in neutrophil, eosinophil, and lymphocyte markers
(P=n.s.; data not shown). There was no evidence of emphy-
sematous changes, fibrosis, or overt inflammation by blinded
histologic grading of H&E- and trichrome-stained lungs
(Fig. 3d).
Evaluation of BAL by proteome array determined that
three cytokines, KC, IL-1ra, and TREM-1, were all elevated
after 4-week-long exposures. These cytokines had >10 %
higher protein levels in e-cigarette-exposed mice compared
to air-exposed experimental controls. KC and TREM-1 had
>10 % higher levels after both 2- and 4-week exposures
(Fig. 3e and Supplemental Fig. S2). Protein levels of several
cytokines in the BAL decreased by >50 % compared to
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Fig. 2 E-cigarette vapor alters macrophage and neutrophil antimicrobial
function. a Alveolar macrophages exposed to EVE Low Nic and EVE
High Nic for 1 h followed by a 2-h recovery period in control media
containing no EV components, and enumeration for live cells, had
decreased antimicrobial activity against MRSA. b Human neutrophils
from blood had decreased antimicrobial activity after 1 h EVE
exposure, followed by a 2-h recovery period in control media and
enumeration for live cells, as demonstrated as higher MRSA survival
during infection. c Nicotine alone suppressed neutrophil antimicrobial
activity. d The main components of e-cigarette liquid, PG, and VG,
contributed to decreased antimicrobial function. When combined with
nicotine (PG + N and VG + N), greater effects were found. e Multiple,
but not all, brands caused similar decrements in neutrophil antimicrobial
function. All conditions were run in triplicate and experiments were run
≥3 times. *P< 0.05, **P< 0.01, ***P< 0.001, ****P< 0.0001
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controls, with two cytokines being >50 % decreased at both 2
and 4 weeks: GM-CSF and IL-3.
Mouse inhalation of e-cigarette vapor is associated
with elevations in acute phase reactant Pentraxin 3
in serum
Cigarette smoke inhalation is known to cause systemic inflam-
mation, measured by rises in acute phase reactants in the se-
rum [26, 27]. To evaluate whether EV inhalation also affects
systemic inflammation, we assessed serum levels of Pentraxin
3, an acute phase reactant in mice. E-cigarette mice had higher
levels of Pentraxin 3 in their serum compared to controls
(Fig. 3f).
E-cigarette vapor suppresses MRSA growth
with moderate bactericidal activity
We previously demonstrated that conventional cigarette
smoke increases the virulence of human pathogen SA by in-
ducing a general stress response [13]. E-cigarettes are a young
invention and as such are frequently compared to their cousin,
the tobacco cigarette. One of the questions most frequently
asked by e-cigarette users and combustible tobacco smokers
alike is: Do e-cigarettes have the same adverse affects as con-
ventional tobacco and to the same degree? Therefore, we de-
signed these studies to determine if e-cigarette vapor promotes
SAvirulence to the same degree as cigarette smoke. We chose
SA for these studies because of its high prevalence (60 % of
the population are colonized intermittently) and its presence in
the nasopharynx where it is exposed to inhalants.
We first examined the growth kinetics during exposure to
EVE. MRSA failed to show logarithmic growth in the pres-
ence of EVE, nicotine, and individual e-cigarette components
PG and VG +/− nicotine (Fig. 4a). We next established that e-
cigarette components were primarily bactericidal in their in-
hibitive function of growth by plating MRSA every hour,
where plated bacteria showed reductions in CFU in PG and
VG +/− nicotine over the first 2 h of exposure (data not
shown). We exposed MRSA to multiple brands of e-
cigarettes and found growth suppression by four of five
brands, suggesting that a common ingredient or mechanism,
Fig. 3 Mice which inhaled e-cigarette vapor for 4 weeks had increased
inflammatory markers in their BAL and serum, compared to controlmice.
a Inhalation of e-cigarette vapor for 1 h per day for 4 weeks did not alter
the quantity of cells in the airways, compared to air-exposed control mice.
b, c There was no difference in the types of cells within the BAL of e-
cigarette vaping mice, with >99 % macrophages in both e-cigarette and
control groups and <1% neutrophils. Scale bars, 20μm. dNo changes of
emphysema, fibrosis, or airway remodeling were found by histologic
grading. Scale bars, 200 μm. e Two inflammatory markers were
elevated in the BAL of e-cigarette mice, with levels >10 % higher
compared to air controls (asterisk), and two immunomodulatory
cytokines had levels <50 % that of controls. f Acute phase reactant
Pentraxin 3 was elevated in the serum of EV-exposed mice compared to
negative and air controls. n = 6 for all groups. **P< 0.01, ***P< 0.001
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such as heating temperature or voltage applied to the e-liquid,
as the root cause (Fig. 4b).
E-cigarette vapor and nicotine induce biofilm formation
in MRSA
Biofilm is a defense mechanism by which bacteria increase
the distance to their cell wall, decreasing the ability of antibi-
otics and other antimicrobials to kill these pathogens. MRSA
exposed to EV (EV-MRSA) had increased biofilm formation
in a dose-dependent manner with respect to nicotine (Fig. 4c).
Interestingly, biofilm formation is induced in response to con-
ventional cigarette smoke as well, which we previously deter-
mined to be induced by oxidative stress [13]. In these studies,
incubation of MRSA with nicotine alone showed higher
biofilm-associated biomass than control, suggesting a novel
pathway in inducing biofilm production that is at play in both
e-cigarette vapor and cigarette smoke exposures.
E-cigarette vapor increases MRSA hydrophobicity
and adherence and invasion of keratinocytes
Hydrophobicity is an important factor in the ability of bacteria
to adhere to the epithelial cells [28, 29]. Bacterial adherence to
the host epithelium is the first step in invasive staphylococcal
infections while promoting colonization of keratinocytes in
the nasopharynx, axilla, and inguinal regions [30]. Here, we
revisit the human keratinocyte HaCaT cell line but evaluate
the effects of e-cigarette vapor on MRSA function, specifical-
ly the ability to adhere to and invade HaCaTcells (which have
not been exposed to e-cigarette vapor). Exposure to EV result-
ed in increased hydrophobicity of MRSA, where 31 % fewer
bacteria were found in the aqueous layer (Fig. 4d). Infection of
Fig. 4 E-cigarette vapor suppresses MRSA growth and induces cell
surface changes. Control bacteria were grown in control media without
EV components. a Nicotine alters MRSA growth in a dose-dependent
fashion, while vaped PG, VG and PG, or VG with nicotine completely
suppress MRSA growth. b Four brands of e-cigarettes suppressed MRSA
growth, while one had no effect. For the remaining studies, bacteria were
growth in e-cigarette vapor (EV) exposed or control media to mid-log
phase, spun, and rinsed 2× in PBS to remove EV. c Nicotine induces
higher biofilm formation by MRSA, as well as EV containing nicotine.
d MRSA became more hydrophobic—fewer bacteria found in the
aqueous layer—with EV exposure. e EV-exposed MRSA were better
able to adhere to human epithelial cells. f EV increased the ability of
MRSA to invade epithelial cells. Nicotine concentration did not affect
the ability of MRSA to adhere to or invade cells. g Exposure to EV
increases MRSA resistance to killing by the human antimicrobial
peptide LL-37. h EV induces changes in MRSA surface charge, leading
to bacterial cell surfaces becoming less negative/more positive, and thus
resistance to binding by cationic antimicrobial molecules. All conditions
were run in triplicate and experiments were run ≥3 times. *P < 0.05,
**P< 0.01, ***P< 0.001, ****P< 0.0001
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HaCaTcells showed increased adherence by EV-MRSAwhen
compared to control (Fig. 4e). Extending the infection time
and quantifying the bacteria solely inside of HaCaT cells
showed that EVexposure increased MRSA’s ability to invade
and persist within human keratinocytes (Fig. 4f).
E-cigarette vapor increases MRSA resistance
to the human antimicrobial peptide LL-37
Increased survival of internalized MRSA suggests that e-
cigarette exposure may induce resistance to killing by epithe-
lial cells. Human keratinocytes both secrete and have the an-
timicrobial peptide LL-37 within their walls. Minimum inhib-
itory concentrations (MICs) of LL-37 for control MRSA and
EV-MRSA were determined. Duplicate samples from four
separate experiments yielded MIC of 7 μM for control
MRSA and 10 μM for EV-MRSA (P=0.014 and Fig. 4g).
An established mechanism bywhich bacteria becomemore
virulent is alterations in surface charge, to make the cells more
cationic. Most bacteria have predominantly anionic surfaces,
which are targeted by the human innate immune system [31,
32]. LL-37’s mode-of-action utilizes charge interactions
where its cationic charge drives the preferential targeting of
negatively charged bacterial lipids [31–33]. The moderate in-
crease in resistance to LL-37, therefore, may be due to mod-
ulation of MRSA surface charge upon EV exposure. Using a
cationic molecule poly-L-Lysine (PLL) to model LL-37
charge interaction, we found reductions in PLL-FITC binding
to MRSA cultured in EVE with low and high nicotine con-
centrations (Fig. 4h). Nicotine level did not impact the binding
of PLL-FITC.
E-cigarette vapor increases MRSA virulence in a mouse
model of pneumonia
To assess the effect of EV exposure on MRSA virulence in a
physiologic setting, we infected mice with MRSA grown in
control media versus EVE (GSL High Nic). All 16 mice in-
fected with control MRSA survived while 25 % of mice in-
fected with EV-MRSA died (P=0.035; Fig. 5a). Bacterial
loads from surviving mice at day 4 demonstrated tenfold
higher bacterial burdens in EV-MRSA-infected lungs
(P<0.01; Fig. 5b). None of the seven control mice harvested
had more than four colonies grow from their lungs
(Supplemental Fig. S3). Within this physiologic model, EV
exposure enhanced MRSA virulence.
E-cigarette vapor induces virulence gene expression
changes in MRSA
To determine the mechanism through which EVE-exposed
MRSA becomes more virulent, we evaluated the expression
of several well-known virulence factors. Relative quantifica-
tion (RQ) values of coagulase coa, intracellular adhesion icaA,
quorum sensing agrA, staphylococcal protein A spa, α-
hemolysin hla, α-phenol soluble modulin psm-α, and
Fig. 5 One 2-h exposure to e-cigarette vapor increases MRSAvirulence,
leading to higher bacterial counts in infected mice, and higher mortality. a
Mice infected intranasally with 3 × 108 CFUMRSA in 75 μL EV-MRSA
led to 25%mortality, while none of themice infected with controlMRSA
died (P= 0.035; n= 16mice per group). b The majority of mice harvested
at 4 days post-EV-MRSA intranasal infection had bacteria remaining in
their lungs, while control MRSA-infected mice primarily had cleared the
bacteria from their lungs (P< 0.01; n= 7 per group). cMRSA exposed to
EV had up-regulation of coa and pvl genes and down-regulation of icaA,
agrA, hla, and psm_a. All conditions were run in triplicate, and
experiments were run ≥3 times
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Panton-Valentine leukocidin pvl were obtained with 16s
rRNA 16s as the housekeeping gene. Expression of coagulase
(coa) and Panton-Valentine leukocidin (pvl) increased by
1.68- and 1.56-fold, respectively, after EVE exposure
(Fig. 5d). Expression of spa did not change with EVE expo-
sure while icaA, agrA, hla, and psm decreased.
Discussion
E-cigarettes are often advertised as a safer alternative to tradi-
tional cigarettes, whose toxic effects of which have been stud-
ied for decades. The data presented here demonstrate the
harmful effects of EVon human epithelial and innate immune
cells in vitro and their impact on the virulence of a common
human pathogen that colonizes the upper airways (Fig. 6).
Direct exposure of human keratinocytes to EV for 15 min
induced cytotoxicity, suggesting that EV contains substances
toxic to mammalian cells. Rapid cell staining with Annexin-V
and EthD-IIIi after e-cigarette vapor exposure suggests that
cells are undergoing necrotic cell death; however, studies
blocking individual pathways would provide further insight.
To evaluate which component(s) may be contributing to cyto-
toxicity, separate components of e-liquid were vaped: PG,
VG, and nicotine. Vapor produced from these separate com-
ponents also caused cell death. Testing vapor created from
e-liquids from seven different companies led to similar results
on mammalian and bacterial cells, demonstrating that our
findings are not limited to one formula or brand. A limitation
of our studies is the use of cell lines instead of primary cells
from human airways. HaCaTs are commonly used for in vitro
toxicology studies [34–36], but in the future, it will be impor-
tant to evaluate EVeffects on primary human airway cells for a
more comprehensive understanding of potential toxicities.
In vivo, lung epithelium has other features to protect it from
inhaled toxins, such as a mucous layer. Therefore, our in vitro
findings may not be replicated in human airways. However,
since it will be decades until we have epidemiologic data on e-
cigarette effects, in vitro models may help by giving some
signal as to how the inhalation of these chemicals may affect
human cells and organ systems. It is well known that cigarette
smoke is highly toxic to human cells, even at very low con-
centrations (10 % cigarette smoke extract kills 100 % of epi-
thelial cells in vitro). Therefore, the cytotoxicity of EV (25 %
EVE kills 40–50% of cells, and 10% EVE kills <5% of cells)
is less than that of cigarette smoke. These results are in agree-
ment with those of Farsalinos et al. [37], who demonstrated
that e-cigarette vapor induced cytotoxicity in cardiomyocytes
but required higher concentrations as compared to conven-
tional cigarette smoke, as well as Schweitzer et al. [38], who
demonstrated that e-cigarette vapor disrupts endothelial bar-
riers and promotes inflammation.
Impaired bacterial killing by neutrophils, macrophages,
and epithelial cells by any method is detrimental to the normal
function of host defenses and may increase susceptibility to
bacterial infections. In our model, it appears that one
Fig. 6 Model of potential e-
cigarette vapor effects on lungs
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mechanism of suppression of innate immunity is via cytotox-
icity by EV, which is suggestive of diffuse cellular damage as
a possible effect of EVinhalation. Inefficient removal of dying
cells may lead to autoimmune-related inflammatory signaling
[39]. And necrotic cell death, which is one of the pathways
induced by EV in our studies, can lead to strong inflammatory
responses [40]. The pro-inflammatory cytokine TREM-1, el-
evated in the BAL of mice exposed to e-cigarette vapor daily
(Fig. 3e), is a mediator of necrotic cell signaling and particu-
larly augments the pro-inflammatory response of monocytes
and macrophages [41]. TREM-1 is also associated with mul-
tiple chronic inflammatory conditions, including COPD, in-
terstitial lung disease (cryptogenic organizing pneumonia),
and rheumatoid arthritis [42–44]. The decreases found in IL-
3 and GM-CSF in the BAL of e-cigarette exposed mice are
concerning for increased susceptibility to bacterial and fungal
infections, as both of these cytokines are important for rapid
activation of host defenses during early stages of infection.
Other groups have demonstrated increased susceptibility to
infection after EVexposure [45, 46], and our findings provide
further evidence that the innate immune system is altered by e-
cigarette exposure.
The absence of changes in BAL cellularity and differential
after inhalation of EV for an hour a day, 5 days per week for
4 weeks, was reassuring in that EV exposure did not induce
neutrophil, eosinophil, or lymphocyte influx. However, the
pattern of elevated cytokines found in the airways of mice that
inhaled EV suggests that airway macrophages and epithelial
cells may be affected by chronic EV inhalation and modulate
the release of immune activation and pro-inflammatory cyto-
kines in response (Fig. 6). Inhalation of cigarette smoke
is known to cause both local and systemic inflammation, lead-
ing to local and systemic disease. Some elevations of pro-
inflammatory cytokines after e-cigarette inhalation are similar
to what is seen with chronic tobacco cigarette inhalation [14].
Also, elevation of Pentraxin 3 in the serum of mice that in-
haled EV for 4 weeks indicates that inhalation of e-cigarettes
may lead to systemic inflammation and disease, such as cor-
onary artery disease and stroke.
Evaluating EV effects on bacterial airway cells found that
human colonizer and pathogen S. aureus became more viru-
lent upon exposure to EV in a murine model of pneumonia.
qRT-PCR demonstrated up-regulation of virulence factors coa
and pvl with EV exposure. Clotting factors such as Coa are
essential for abscess formation in Staphylococcus [47], and
therefore the elevated expression of coa is consistent with
the abundance of abscesses that were seen only in lungs of
mice infected with EVE-MRSA. PVL is postulated to be a
pore-forming cytotoxin involved in leukocyte destruction
and necrosis, and its increased expression likely contributes
to MRSA pathogenesis [48]. Both of these factors are associ-
ated with increased virulence, but the mechanism of increased
expression is unknown as yet [49, 50]. In vitro assays showed
increased biofilm formation, shifts in cell surface towards a
more positive charge, and resistance to human antimicrobial
peptide LL-37. Biofilm and cationic surface charge both
enhance S. aureus survival by making the bacteria unrecog-
nizable and disrupting charge interaction that drives LL-37
function. Decreased susceptibility of S. aureus to human an-
timicrobial peptides is an alarming concern for the current
state of antibacterial therapy where the antibiotic development
pipeline is running dry. Overall, these data suggest that
Staphylococcal infections in vapers may be more deadly and
difficult to treat. Subsequent experiments with PG andVG+/−
nicotine exposure may help distinguish which specific com-
ponents are up-regulating the virulence factors and how other
gene expressions may be modulated by EVexposure.
In this paper, we demonstrate that e-cigarette vapor in-
creases the virulence potential of S. aureus while impairing
innate immune function and inducing cytotoxicity in human
cells with direct exposure (Fig. 6). Our data suggest that vaping
e-liquid has the potential to decrease host ability to fight infec-
tion, promote virulence in bacterial colonizers of the airways,
and promote inflammation, overall having the potential to
cause significant inflammatory lung and systemic diseases.
Acknowledgments This work was supported by the VA Career De-
velopment Award (CDA)-2, award no. 1IK2BX001313, PI Crotty
Alexander, from the U.S. Department of Veterans Affairs, Biomedical
Laboratory Research and Development (BLR&D) Program. Thank you
to Drs. Ross Corriden and Simon Döhrmann for their technical support.
Thank you to Dr. Atul Malhotra for his guidance and support.
Author contributions JHH, EM, WMO, SB, SD, and LCA designed
the research. JHH, ML, KS, SE, SD, EM, DM, AM, SD, SB, WMO, and
LCA performed the research and analyzed the data. JHH, SE, SB, ML,
DTP,WMO, and LCA performed statistical analyses and edited the paper.
JHH, SD, SB, and LCAwrote the paper.
Compliance with Ethical Standards
Conflict of Interest The authors declare that they have no competing
interests.
References
1. King BA (2013) Notes from the field: electronic cigarette use
among middle and high school students—United States, 2011-
2012 Morbidity and Mortality Weekly Report (MMWR) Centers
for Disease Control and Prevention (CDC), Atlanta, pp. 729–730.
2. Czoli CD, Hammond D, White CM (2014) Electronic cigarettes in
Canada: prevalence of use and perceptions among youth and young
adults. Can J Public Health Revue Canadienne de Sante Publique
105:e97–e102
3. Kinnunen JM, Ollila H, El-Amin SE, Pere LA, Lindfors PL,
Rimpela AH (2014) Awareness and determinants of electronic cig-
arette use among Finnish adolescents in 2013: a population-based
study. Tob Control. doi:10.1136/tobaccocontrol-2013-051512
J Mol Med (2016) 94:667–679 677
4. Lee S, Grana RA, Glantz SA (2014) Electronic cigarette use among
Korean adolescents: a cross-sectional study of market penetration,
dual use, and relationship to quit attempts and former smoking. J
Adolesc Health: Off Publ Soc Adolesc Med 54:684–690
5. Bostean G, Trinidad DR, McCarthy WJ (2015) E-cigarette use
among never-smoking California students. American journal of
public health: e1-e3. DOI 10.2105/AJPH.2015.302899
6. Sutfin EL, McCoy TP, Morrell HE, Hoeppner BB, Wolfson M
(2013) Electronic cigarette use by college students. Drug Alcohol
Depend 131:214–221
7. Regan AK, Promoff G, Dube SR, Arrazola R (2013) Electronic
nicotine delivery systems: adult use and awareness of the 'e-
cigarette' in the USA. Tob Control 22:19–23
8. Brown J, West R, Beard E, Michie S, Shahab L, McNeill A (2014)
Prevalence and characteristics of e-cigarette users in Great Britain:
findings from a general population survey of smokers. Addict
Behav 39:1120–1125
9. Dawkins L, Turner J, Roberts A, Soar K (2013) 'Vaping' profiles
and preferences: an online survey of electronic cigarette users.
Addiction 108:1115–1125
10. Bauguess AJ (2014) How to make your own e-liquid (e-juice).
ecigvape.com.
11. Flouris AD, Chorti MS, Poulianiti KP, Jamurtas AZ, Kostikas K,
Tzatzarakis MN, Wallace Hayes A, Tsatsakis AM, Koutedakis Y
(2013) Acute impact of active and passive electronic cigarette
smoking on serum cotinine and lung function. Inhal Toxicol 25:
91–101
12. Liu GY (2009) Molecular pathogenesis of Staphylococcus aureus
infection. Pediatr Res 65:71R–77R
13. McEachern EK, Hwang JH, Sladewski KM, Nicatia S, Dewitz C,
Mathew DP, Nizet V, Alexander LE (2015) Analysis of the effects
of cigarette smoke on staphylococcal virulence phenotypes. Infect
Immun 83:2443–2452
14. Crotty Alexander LE, Shin S, Hwang JH (2015) Inflammatory dis-
eases of the lung induced by conventional cigarette smoke: a re-
view. Chest. doi:10.1378/chest.15-0409
15. Foster KA, Oster CG, Mayer MM, Avery ML, Audus KL (1998)
Characterization of the A549 cell line as a type II pulmonary epi-
thelial cell model for drug metabolism. Exp Cell Res 243:359–366
16. Grando SA (2008) Basic and clinical aspects of non-neuronal ace-
tylcholine: biological and clinical significance of non-canonical li-
gands of epithelial nicotinic acetylcholine receptors. J Pharmacol
Sci 106:174–179
17. Thunnissen FB (2009) Acetylcholine receptor pathway and lung
cancer. J Thorac Oncol: Off Publ Int Assoc Study Lung Cancer 4:
943–946
18. BermudezY, Benavente CA,Meyer RG, CoyleWR, JacobsonMK,
Jacobson EL (2011) Nicotinic acid receptor abnormalities in human
skin cancer: implications for a role in epidermal differentiation.
PLoS ONE 6, e20487. doi:10.1371/journal.pone.0020487
19. Reynolds PR, Allison CH, Willnauer CP (2010) TTF-1 regulates
alpha5 nicotinic acetylcholine receptor (nAChR) subunits in prox-
imal and distal lung epithelium. Respir Res 11:175
20. Ma X, Jia Y, Zu S, Li R, Zhao Y, Xiao D, Dang N, Wang Y (2014)
alpha5 Nicotinic acetylcholine receptor mediates nicotine-induced
HIF-1alpha and VEGF expression in non-small cell lung cancer.
Toxicol Appl Pharmacol 278:172–179
21. Comer DM, Elborn JS, Ennis M (2014) Inflammatory and cytotox-
ic effects of acrolein, nicotine, acetylaldehyde and cigarette smoke
extract on human nasal epithelial cells. BMC Pulm Med 14:32
22. Streck E, Jorres RA, Huber RM, Bergner A (2010) Effects of cig-
arette smoke extract and nicotine on bronchial tone and
acetylcholine-induced airway contraction in mouse lung slices. J
Investig Allergol Clin Immunol 20:324–330
23. Askarian F, Sangvik M, Hanssen AM, Snipen L, Sollid JU,
Johannessen M (2014) Staphylococcus aureus nasal isolates from
healthy individuals cause highly variable host cell responses
in vitro: the Tromso Staph and Skin Study. Pathog Dis 70:158–166
24. Pegtel DM, Subramanian A, Sheen TS, Tsai CH, Golub TR,
Thorley-Lawson DA (2005) Epstein-Barr-virus-encoded LMP2A
induces primary epithelial cell migration and invasion: possible role
in nasopharyngeal carcinoma metastasis. J Virol 79:15430–15442
25. Condliffe AM, Kitchen E, Chilvers ER (1998) Neutrophil priming:
pathophysiological consequences and underlying mechanisms.
Clin Sci 94:461–471
26. Bermudez EA, Rifai N, Buring J, Manson JE, Ridker PM (2002)
Interrelationships among circulating interleukin-6, C-reactive pro-
tein, and traditional cardiovascular risk factors in women.
Arterioscler Thromb Vasc Biol 22:1668–1673
27. Rohde LE, Hennekens CH, Ridker PM (1999) Survey of C-reactive
protein and cardiovascular risk factors in apparently healthy men.
Am J Cardiol 84:1018–1022
28. Magnusson KE (1982) Hydrophobic interaction—a mechanism of
bacterial binding. Scand J Infect Dis Suppl 33:32–36
29. Dahlback B, Hermansson M, Kjelleberg S, Norkrans B (1981) The
hydrophobicity of bacteria—an important factor in their initial ad-
hesion at the air-water interface. Arch Microbiol 128:267–270
30. Yang ES, Tan J, Eells S, Rieg G, Tagudar G, Miller LG (2010)
Body site colonization in patients with community-associated
methicillin-resistant Staphylococcus aureus and other types of S.
aureus skin infections. Clin Microbiol Infect: Off Publ Eur Soc
Clin Microbiol Infect Dis 16:425–431
31. Wang G (2008) Structures of human host defense cathelicidin LL-
37 and its smallest antimicrobial peptide KR-12 in lipid micelles. J
Biol Chem 283:32637–32643
32. Neville F, Cahuzac M, Konovalov O, Ishitsuka Y, Lee KY,
Kuzmenko I, Kale GM, Gidalevitz D (2006) Lipid headgroup dis-
crimination by antimicrobial peptide LL-37: insight into mecha-
nism of action. Biophys J 90:1275–1287
33. Neville F, Gidalevitz D, Kale G, Nelson A (2007) Electrochemical
screening of anti-microbial peptide LL-37 interaction with phos-
pholipids. Bioelectrochemistry 70:205–213
34. Park EJ, Lee GH, Yoon C, Jeong U, Kim Y, Cho MH, Kim DW
(2015) Biodistribution and toxicity of spherical aluminum oxide
nanoparticles. J Appl Toxicol: JAT. doi:10.1002/jat.3233
35. Viard I, Wehrli P, Bullani R, Schneider P, Holler N, Salomon D,
Hunziker T, Saurat JH, Tschopp J, French LE (1998) Inhibition of
toxic epidermal necrolysis by blockade of CD95 with human intra-
venous immunoglobulin. Science 282:490–493
36. Herzog E, Casey A, Lyng FM, Chambers G, Byrne HJ, DavorenM
(2007) A new approach to the toxicity testing of carbon-based
nanomaterials—the clonogenic assay. Toxicol Lett 174:49–60
37. Farsalinos KE, Romagna G, Allifranchini E, Ripamonti E,
Bocchietto E, Todeschi S, Tsiapras D, Kyrzopoulos S, Voudris V
(2013) Comparison of the cytotoxic potential of cigarette smoke
and electronic cigarette vapour extract on culturedmyocardial cells.
Int J Environ Res Public Health 10(10):5146–5162
38. Schweitzer KS, Chen SX, Law S, VanDemarkM, Poirier C, Justice
MJ, HubbardWC, Kim ES, Lai X,WangM et al (2015) Endothelial
disruptive proinflammatory effects of nicotine and e-cigarette vapor
exposures. Am J Physiol Lung Cell Mol Physiol 309(2):L175–
L187
39. Savill J, Dransfield I, Gregory C, Haslett C (2002) A blast from the
past: clearance of apoptotic cells regulates immune responses. Nat
Rev Immunol 2:965–975
40. KaczmarekA, Vandenabeele P, KryskoDV (2013) Necroptosis: the
release of damage-associated molecular patterns and its physiolog-
ical relevance. Immunity 38:209–223
41. El Mezayen R, El Gazzar M, Seeds MC, McCall CE, Dreskin SC,
Nicolls MR (2007) Endogenous signals released from necrotic cells
augment inflammatory responses to bacterial endotoxin. Immunol
Lett 111:36–44
678 J Mol Med (2016) 94:667–679
42. RadsakMP, Taube C, Haselmayer P, Tenzer S, Salih HR,Wiewrodt
R, Buhl R, Schild H (2007) Soluble triggering receptor expressed
on myeloid cells 1 is released in patients with stable chronic ob-
structive pulmonary disease. Clin Dev Immunol 2007:52040
43. Papanikolaou IC, Boki KA, Giamarellos-Bourboulis EJ, Kotsaki A,
Kagouridis K, Karagiannidis N, Polychronopoulos VS (2015)
Innate immunity alterations in idiopathic interstitial pneumonias
and rheumatoid arthritis-associated interstitial lung diseases.
Immunol Lett 163:179–186
44. Molad Y, Ofer-Shiber S, Pokroy-Shapira E, Oren S, Shay-Aharoni
H, Babai I (2015) Soluble triggering receptor expressed on myeloid
cells-1 is a biomarker of anti-CCP-positive, early rheumatoid arthri-
tis. Eur J Clin Investig 45:557–564
45. Sussan TE, Gajghate S, Thimmulappa RK, Ma J, Kim JH, Sudini
K, Consolini N, Cormier SA, Lomnicki S, Hasan F et al (2015)
Exposure to electronic cigarettes impairs pulmonary anti-bacterial
and anti-viral defenses in a mouse model. PLoS ONE 10(2),
e0116861. doi:10.1371/journal.pone.0116861
46. Wu Q, Jiang D, Minor M, Chu HW (2014) Electronic cigarette
liquid increases inflammation and virus infection in primary human
airway epithelial cells. PLoS ONE 9(9), e108342. doi:10.1371/
journal.pone.0108342
47. Cheng AG, McAdow M, Kim HK, Bae T, Missiakas DM,
Schneewind O (2010) Contribution of coagulases towards
Staphylococcus aureus disease and protective immunity. PLoS
Pathog 6, e1001036. doi:10.1371/journal.ppat.1001036
48. Hamilton SM, Bryant AE, Carroll KC, Lockary V, Ma Y, McIndoo
E, Miller LG, Perdreau-Remington F, Pullman J, Risi GF et al
(2007) In vitro production of panton-valentine leukocidin among
strains of methicillin-resistant Staphylococcus aureus causing di-
verse infections. Clin Infect Dis: Off Publ Infect Dis Soc Am 45:
1550–1558
49. Montgomery CP, Boyle-Vavra S, Adem PV, Lee JC, Husain AN,
Clasen J, DaumRS (2008) Comparison of virulence in community-
associated methicillin-resistant Staphylococcus aureus pulsotypes
USA300 and USA400 in a rat model of pneumonia. J Infect Dis
198:561–570
50. Gillet Y, Issartel B, Vanhems P, Fournet JC, Lina G, Bes M,
Vandenesch F, Piemont Y, Brousse N, Floret D et al (2002)
Association between Staphylococcus aureus strains carrying
gene for Panton-Valentine leukocidin and highly lethal
necrotising pneumonia in young immunocompetent patients.
Lancet 359:753–759
51. Crotty Alexander LE, Maisey HC, Timmer AM, Rooijakkers SH,
Gallo RL, von Kockritz-BlickwedeM,Nizet V (2010)M1T1 group
A streptococcal pili promote epithelial colonization but diminish
systemic virulence through neutrophil extracellular entrapment. J
Mol Med 88:371–381
J Mol Med (2016) 94:667–679 679
